Arika S Feils

6PUBLICATIONS
31CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 25, 2025
Immune-mediated Engagement of T Regulatory Cells with Tumor Cells Results in Trogocytosis and Tumor Cell Killing.

Amy K Erbe, Arika S Feils, Anqi Gao

|Nov 24, 2025
Divergent role of CD8 T cells with distinct metabolic phenotypes during curative radio-immunotherapy in hot versus cold tumors.

Alexa R Heaton, Nathaniel J Burkard, Anqi Gao

|Jun 10, 2024
Targeting both GD2 and B7-H3 using bispecific antibody improves tumor selectivity for GD2-positive tumors.

Zachary T Rosenkrans, Amy K Erbe, Nathan B Clemons

|Feb 24, 2023
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial.

A S Feils, A K Erbe, J Birstler

|Feb 23, 2023
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group.

Amy K Erbe, Mitch B Diccianni, Rajen Mody

|Jan 13, 2023
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination.

Peter M Carlson, Ravi B Patel, Jen Birstler

Pageof 1

Frequent Collaborators

6 joint publications

Amy K Erbe

6 joint publications

Paul M Sondel

3 joint publications

Alexander L Rakhmilevich

2 joint publications

Noah W Tsarovsky